Anthony H. V. Schapira And NotEspagne
List of bibliographic references
Number of relevant bibliographic references: 11.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000453 | Matthew E. Gegg [Royaume-Uni] ; J. Mark Cooper ; Kai-Yin Chau ; Manuel Rojo ; Anthony H. V. Schapira ; Jan-Willem Taanman | Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy |
| 000567 | Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 000569 | Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000732 | Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000C20 | C. Warren Olanow [États-Unis] ; Karl Kieburtz [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] | Why have we failed to achieve neuroprotection in Parkinson's disease? |
| 000C50 | Anthony H. V. Schapira [Royaume-Uni] | The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease |
| 000E13 | Anthony H. V. Schapira [Royaume-Uni] ; C. Warren Olanow [États-Unis] | Drug selection and timing of initiation of treatment in early Parkinson's disease |
| 000F60 | Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
| 001050 | Anthony H. V. Schapira [Royaume-Uni] | Future directions in the treatment of Parkinson's disease |
| 001763 | Thomas T. Warner [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Genetic and environmental factors in the cause of Parkinson's disease |
| 002649 | Dexter [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia |
| This area was generated with Dilib version V0.6.23. |  |